EUVIMEDScopri EUVIMED
Crossref

Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2

Arthur K Melkonian, Gagik V Hakobyan iD

Biotechnology and Applied Biochemistry · 2024

DOI: 10.1002/bab.2597 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2024. Written by Arthur K Melkonian and 1 co-authors. Institution: Promtest, Yerevan, Armenia. Major MEDLINE topics: Antiviral Agents, SARS-CoV-2, Mesocricetus, COVID-19 Drug Treatment. Cited 1 times so far (Crossref); 50 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose of this article is to study the possible direct antiviral effect of “Armenikum” on SARS‐CoV‐2, conduct an in vitro study on the SARS‐CoV‐2 encephalomocarditis virus, and an in vivo study on the Syrian hamster model. Human coronavirus SARS‐CoV‐2 (delta strain) was used as the virus. Two groups of four‐specimen hamsters were used to study the therapeutic activity of the drug during 48 h after infecting. One group of hamsters served as positive control and was infected with the virus at a similar dose as experimental one and was used as a control of pathology induced by the viral infection till the end of the experiment. Another group of hamsters (four of them) was injected physiological solution and was used as a control. The Syrian hamsters underwent a clinical blood test and computed tomography. “Armenikum” in the form of an injection has a significant antiviral effect on the human coronavirus SARS‐CoV‐2, credibly reducing the titers of the virus and the time of its elimination from the Syrian hamsters, significantly mitigating the viral infection. “Armenikum” in the form of an injection drug almost completely removes the pathological effect of the virus in the lungs of the hamsters.

Subjects

MeSH terms (MEDLINE)

Antiviral AgentsSARS-CoV-2MesocricetusCOVID-19 Drug TreatmentAnimalsHumansCricetinaeCOVID-19Chlorocebus aethiopsVero CellsMale

Author keywords

SARS‐CoV‐2antiviral therapeutic action“Armenikum,” dextrin

Substances

Antiviral Agents

Authors and institutions

  • Promtest, Yerevan, Armenia.
  • Department of Oral and Maxillofacial Surgery, University of Yerevan State Medical University, Yerevan, Armenia.

ORCID profiles: Gagik V Hakobyan

Cite

APA

Melkonian, A. K., & Hakobyan, G. V. (2024). Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2597

Vancouver

Melkonian AK, Hakobyan GV. Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2597

BibTeX
@article{Melkonian2024,
  author = {Melkonian, Arthur K and Hakobyan, Gagik V},
  title = {Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2024},
  doi = {10.1002/bab.2597}
}
Start for free →